Examples of using Combination with insulin in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Combination with insulin.
Actos 15 mg tablets may also be used in combination with insulin.
Hypoglycaemia in combination with insulin or sulphonylurea.
Localised swelling(oedema) has also been experienced very commonly in patients taking Paglitaz in combination with insulin.
Of patients were taking metformin in combination with insulin in this trial.
Vildagliptin in combination with insulin significantly decreased HbA1c compared with placebo.
Hypoglycaemia when Eperzan is used in combination with insulin or sulphonylurea.
Some patients have experienced the following side effects while taking this medicine in combination with insulin.
The use of sitagliptin in combination with insulin has not been adequately studied.
Patients should be alerted to the risk of hypoglycaemia especially when used in combination with insulin or pioglitazone.
The use of sitagliptin in combination with insulin has not been adequately studied.
Heart failure has been experienced commonly(1 to 10 users in 100)in patients taking pioglitazone in combination with insulin.
The use of Efficib in combination with insulin has not been adequately studied.
Hypoglycaemia has been observed when sitagliptin was used in combination with insulin or a sulphonylurea.
In combination with insulin, the current insulin dose can be continued upon initiation of pioglitazone therapy.
Low blood sugar(hypoglycaemia)when you use Eperzan in combination with insulin or sulphonylurea.
When Efficib is used in combination with insulin, a lower dose of insulin may be required to reduce the risk of hypoglycaemia see section 4.4.
Heart failure has been experienced commonly(up to 1 in 10 people)in patients taking pioglitazone in combination with insulin.
When this medicinal product is used in combination with insulin, a lower dose of insulin may be required to reduce the risk of hypoglycaemia see section 4.4.
An increased incidence of cardiac failure has been observed in clinical trials when rosiglitazone is used in combination with insulin.
Symptoms of low blood sugar(hypoglycaemia)may occur when Vipidia is taken in combination with insulin or sulphonylureas e.g. glipizide, tolbutamide, glibenclamide.
Localised swelling(oedema) has also been experienced very commonly(may affect more than 1 in 10 people)in patients taking pioglitazone in combination with insulin.
One patient reported severe hypoglycaemia with Trulicity 1.5 mg in combination with insulin glargine and none with placebo.
When Onglyza is used in combination with insulin or a sulphonylurea, a lower dose of the insulin or sulphonylurea may be required to reduce the risk of hypoglycaemia see section 4.4.
Some patients have experienced the following side effects while taking sitagliptin in combination with insulin with or without metformin.
In combination with insulin(i.e. triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.
Cases of cardiac failure have been reported when pioglitazone was used in combination with insulin, especially in patients with risk factors for development of cardiac heart failure.
Heart failure has been reported rarely with marketing use of pioglitazone, butmore frequently when pioglitazone was used in combination with insulin or in patients with a history of cardiac failure.
There have been cases of cardiac failure reported from the market when pioglitazone was used in combination with insulinor in patients with a history of cardiac failure; patients should be observed for signs andsymptoms of heart failure, weight gain and oedema when pioglitazone is used in combination with insulin.
Table 3 Adverse reactions reported in patients who received vildagliptin 100 mg daily in combination with insulin(with or without metformin) in double-blind studies N=371.